Summary
Updated Aug 31, 2026
Michael C. Quirk files SEC Form 4 reports at Sage Therapeutics, Inc. (SAGE). 1 SEC Form 4 filing on record, dated 31 July 2025.
Recent Transactions
2Every recent SEC Form 4 transaction Michael C. Quirk has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Michael C. Quirk's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Third Rock Ventures V, L.P. - $34.39M of RAPP open-market activity in the last 12 months
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Michael B. Petras Jr. - $33.51M of SHC open-market activity in the last 12 months
- Reuven Yeganeh - $33.32M of PHGE open-market activity in the last 12 months
- Adage Capital Management, L.P. - $33.20M of PRAX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael C. Quirk?
Michael C. Quirk is a corporate insider of Sage Therapeutics, Inc. (SAGE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael C. Quirk last file a Form 4?
The only primary Form 4 on record is dated 31 July 2025.
Where can I see all of Michael C. Quirk's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael C. Quirk and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
